301080 百普赛斯
已收盘 11-15 15:00:00
资讯
新帖
简况
百普赛斯涨6.07%,开源证券一周前给出“买入”评级
证券之星 · 11-11
百普赛斯涨6.07%,开源证券一周前给出“买入”评级
百普赛斯:10月30日接受机构调研,华夏基金、南方基金等多家机构参与
证券之星 · 11-04
百普赛斯:10月30日接受机构调研,华夏基金、南方基金等多家机构参与
百普赛斯(301080)2024年三季报简析:增收不增利
证券之星 · 10-31
百普赛斯(301080)2024年三季报简析:增收不增利
开源证券:给予百普赛斯买入评级
证券之星 · 10-30
开源证券:给予百普赛斯买入评级
开源证券给予百普赛斯买入评级:常规业务环比增速提升,高费用投入影响短期利润
每日经济新闻 · 10-30
开源证券给予百普赛斯买入评级:常规业务环比增速提升,高费用投入影响短期利润
百普赛斯(301080.SZ)发布前三季度业绩,净利润8349万元,下降34.85%
智通财经 · 10-29
百普赛斯(301080.SZ)发布前三季度业绩,净利润8349万元,下降34.85%
图解百普赛斯三季报:第三季度单季净利润同比减26.64%
证券之星 · 10-29
图解百普赛斯三季报:第三季度单季净利润同比减26.64%
百普赛斯(301080)9月30日股东户数1.41万户,较上期减少9.29%
证券之星 · 10-29
百普赛斯(301080)9月30日股东户数1.41万户,较上期减少9.29%
10月29日百普赛斯跌5.30%,圆信永丰兴源灵活配置混合A基金重仓该股
证券之星 · 10-29
10月29日百普赛斯跌5.30%,圆信永丰兴源灵活配置混合A基金重仓该股
10月25日百普赛斯涨6.54%,圆信永丰医药健康基金重仓该股
证券之星 · 10-25
10月25日百普赛斯涨6.54%,圆信永丰医药健康基金重仓该股
百普赛斯涨6.54%,开源证券一个月前给出“买入”评级
证券之星 · 10-25
百普赛斯涨6.54%,开源证券一个月前给出“买入”评级
百普赛斯(301080)5276.86万股限售股将于10月18日解禁,占总股本43.97%
证券之星 · 10-18
百普赛斯(301080)5276.86万股限售股将于10月18日解禁,占总股本43.97%
百普赛斯(301080.SZ)5276.86万股限售股将于10月18日上市流通
智通财经 · 10-15
百普赛斯(301080.SZ)5276.86万股限售股将于10月18日上市流通
百普赛斯:约5276.86万股限售股10月18日解禁
每日经济新闻 · 10-15
百普赛斯:约5276.86万股限售股10月18日解禁
10月11日百普赛斯跌5.88%,圆信永丰聚优股票A基金重仓该股
证券之星 · 10-11
10月11日百普赛斯跌5.88%,圆信永丰聚优股票A基金重仓该股
10月9日百普赛斯跌12.77%,圆信永丰聚优股票A基金重仓该股
证券之星 · 10-09
10月9日百普赛斯跌12.77%,圆信永丰聚优股票A基金重仓该股
9月27日百普赛斯涨7.22%,圆信永丰聚优股票A基金重仓该股
证券之星 · 09-27
9月27日百普赛斯涨7.22%,圆信永丰聚优股票A基金重仓该股
百普赛斯涨7.22%,开源证券四周前给出“买入”评级
证券之星 · 09-27
百普赛斯涨7.22%,开源证券四周前给出“买入”评级
百普赛斯(301080.SZ)授出22.01万股预留限制性股票
智通财经 · 09-20
百普赛斯(301080.SZ)授出22.01万股预留限制性股票
百普赛斯新提交1件商标注册申请
证券之星 · 09-07
百普赛斯新提交1件商标注册申请
加载更多
公司概况
公司名称:
北京百普赛斯生物科技股份有限公司
所属行业:
研究和试验发展
上市日期:
2021-10-18
主营业务:
北京百普赛斯生物科技股份有限公司是一家专业提供重组蛋白等关键生物试剂产品及技术服务的高新技术企业。公司主要产品为重组蛋白、试剂盒、抗体、生物分析检测服务。
发行价格:
112.50
{"stockData":{"symbol":"301080","market":"SZ","secType":"STK","nameCN":"百普赛斯","latestPrice":45.61,"timestamp":1731654207000,"preClose":45.11,"halted":0,"volume":4108503,"delay":0,"floatShares":90586200,"shares":120000000,"eps":0.9078,"marketStatus":"已收盘","marketStatusCode":5,"change":0.5,"latestTime":"11-15 15:00:00","open":44.79,"high":47.7,"low":44.3,"amount":190000000,"amplitude":0.0754,"askPrice":45.61,"askSize":18,"bidPrice":45.6,"bidSize":2,"shortable":0,"etf":0,"ttmEps":0.9078,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731893400000},"adr":0,"adjPreClose":45.11,"symbolType":"stock","openAndCloseTimeList":[[1731634200000,1731641400000],[1731646800000,1731654000000]],"highLimit":49.62,"lowLimit":40.6,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":120000000,"pbRate":2.1,"roa":"--","roe":"3.23%","epsLYR":1.2801,"committee":0.145455,"marketValue":5473000000,"floatMarketCap":4132000000,"peRate":50.242343,"changeRate":0.0111,"turnoverRate":0.0454,"status":0},"requestUrl":"/m/hq/s/301080","defaultTab":"news","newsList":[{"id":"2482274412","title":"百普赛斯涨6.07%,开源证券一周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2482274412","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482274412?lang=zh_cn&edition=full","pubTime":"2024-11-11 16:25","pubTimestamp":1731313514,"startTime":"0","endTime":"0","summary":"今日百普赛斯(301080)涨6.07%,收盘报46.46元。2024年10月30日,开源证券研究员余汝意,聂媛媛发布了对百普赛斯的研报《公司信息更新报告:常规业务环比增速提升,高费用投入影响短期利润》,该研报对百普赛斯给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为67.81%。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为西南证券的杜向阳。百普赛斯(301080)个股概况:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111100020158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","161027"],"gpt_icon":0},{"id":"2480983584","title":"百普赛斯:10月30日接受机构调研,华夏基金、南方基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2480983584","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480983584?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:49","pubTimestamp":1730731778,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年11月4日百普赛斯发布公告称公司于2024年10月30日接受机构调研,华夏基金、南方基金、长城基金、广发基金、东吴证券、兴业证券、招商证券、其他89家机构参与。2024 年前三季度,公司实现营业收入 46,348.52万元,同比增长 12.34%,归属于上市公司股东的净利润 8,349.00 万元。百普赛斯主营业务:提供重组蛋白等关键生物试剂产品及技术服务。百普赛斯2024年三季报显示","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110400031876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","BK0216"],"gpt_icon":0},{"id":"2479798134","title":"百普赛斯(301080)2024年三季报简析:增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2479798134","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479798134?lang=zh_cn&edition=full","pubTime":"2024-10-31 06:45","pubTimestamp":1730328350,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期百普赛斯发布2024年三季报。根据财报显示,百普赛斯增收不增利。其中,毛利率91.33%,同比减0.04%,净利率17.05%,同比减41.46%,销售费用、管理费用、财务费用总计1.87亿元,三费占营收比40.44%,同比增26.22%,每股净资产21.43元,同比减0.61%,每股经营性现金流0.74元,同比增33.97%,每股收益0.7元,同比减34.71%证券之星价投圈财报分析工具显示:业务评价:公司去年的ROIC为3.55%,资本回报率不强。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100009667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","BK0216"],"gpt_icon":0},{"id":"2479733680","title":"开源证券:给予百普赛斯买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479733680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479733680?lang=zh_cn&edition=full","pubTime":"2024-10-30 23:43","pubTimestamp":1730302981,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,聂媛媛近期对百普赛斯进行研究并发布了研究报告《公司信息更新报告:常规业务环比增速提升,高费用投入影响短期利润》,本报告对百普赛斯给出买入评级,当前股价为41.01元。最新盈利预测明细如下:该股最近90天内共有6家机构给出评级,买入评级4家,增持评级2家;过去90天内机构目标均价为49.9。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000045142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","161027"],"gpt_icon":0},{"id":"2479781039","title":"开源证券给予百普赛斯买入评级:常规业务环比增速提升,高费用投入影响短期利润","url":"https://stock-news.laohu8.com/highlight/detail?id=2479781039","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479781039?lang=zh_cn&edition=full","pubTime":"2024-10-30 22:19","pubTimestamp":1730297940,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 开源证券10月30日发布研报称,给予百普赛斯(301080.SZ)买入评级。评级理由主要包括:1)常规业务稳健增长,高费用投入影响短期利润;2)常规业务环比提速,海外常规业务贡献核心业绩弹性;3)公司持续加大研发投入,增加品类覆盖率,利润端增速短暂承压。风险提示:全球新药研发需求不及预期、核心成员流失、新产品开发失败等。(文章来源:每日经济新闻)\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-30/doc-incukear6535636.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-30/doc-incukear6535636.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["161027","301080"],"gpt_icon":0},{"id":"2479473882","title":"百普赛斯(301080.SZ)发布前三季度业绩,净利润8349万元,下降34.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479473882","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479473882?lang=zh_cn&edition=full","pubTime":"2024-10-29 17:38","pubTimestamp":1730194738,"startTime":"0","endTime":"0","summary":"智通财经APP讯, 百普赛斯(301080.SZ)发布2024年三季度报告,该公司前三季度营业收入为4.63亿元,同比增长12.34%。归属于上市公司股东的净利润为8349万元,同比减少34.85%。归属于上市公司股东的扣除非经常性损益的净利润为8353.95万元,同比减少32.85%。基本每股收益为0.6973元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1202492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301080"],"gpt_icon":0},{"id":"2479478416","title":"图解百普赛斯三季报:第三季度单季净利润同比减26.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479478416","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479478416?lang=zh_cn&edition=full","pubTime":"2024-10-29 17:31","pubTimestamp":1730194318,"startTime":"0","endTime":"0","summary":"证券之星消息,百普赛斯2024年三季报显示,公司主营收入4.63亿元,同比上升12.34%;归母净利润8349.0万元,同比下降34.85%;扣非净利润8353.95万元,同比下降32.85%;其中2024年第三季度,公司单季度主营收入1.64亿元,同比上升13.81%;单季度归母净利润2679.46万元,同比下降26.64%;单季度扣非净利润2584.51万元,同比下降24.46%;负债率8.4%,投资收益-191.65万元,财务费用-3802.09万元,毛利率91.33%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900032196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080"],"gpt_icon":0},{"id":"2479420485","title":"百普赛斯(301080)9月30日股东户数1.41万户,较上期减少9.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479420485","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479420485?lang=zh_cn&edition=full","pubTime":"2024-10-29 17:21","pubTimestamp":1730193668,"startTime":"0","endTime":"0","summary":"证券之星消息,近日百普赛斯披露,截至2024年9月30日公司股东户数为1.41万户,较6月30日减少1447.0户,减幅为9.29%。在生物制品行业个股中,百普赛斯股东户数低于行业平均水平,截至9月30日,生物制品行业平均股东户数为3.35万户。从股价来看,2024年6月30日至2024年9月30日,百普赛斯区间涨幅为24.2%,在此期间股东户数减少1447.0户,减幅为9.29%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900031758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","BK0216"],"gpt_icon":0},{"id":"2479421281","title":"10月29日百普赛斯跌5.30%,圆信永丰兴源灵活配置混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2479421281","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479421281?lang=zh_cn&edition=full","pubTime":"2024-10-29 16:23","pubTimestamp":1730190185,"startTime":"0","endTime":"0","summary":"证券之星消息,10月29日百普赛斯跌5.30%,收盘报40.88元,换手率3.13%,成交量2.83万手,成交额1.18亿元。根据2024基金Q3季报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为圆信永丰兴源灵活配置混合A。圆信永丰兴源灵活配置混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900027630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301080"],"gpt_icon":0},{"id":"2478672006","title":"10月25日百普赛斯涨6.54%,圆信永丰医药健康基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2478672006","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478672006?lang=zh_cn&edition=full","pubTime":"2024-10-25 16:21","pubTimestamp":1729844491,"startTime":"0","endTime":"0","summary":"证券之星消息,10月25日百普赛斯涨6.54%,收盘报42.36元,换手率5.68%,成交量5.14万手,成交额2.12亿元。根据2024基金Q3季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为圆信永丰医药健康。圆信永丰医药健康目前规模为1.62亿元,最新净值1.5943,较上一交易日上涨0.25%,近一年下跌1.28%。圆信永丰医药健康的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500026589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","BK0216"],"gpt_icon":0},{"id":"2478720226","title":"百普赛斯涨6.54%,开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2478720226","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478720226?lang=zh_cn&edition=full","pubTime":"2024-10-25 16:21","pubTimestamp":1729844485,"startTime":"0","endTime":"0","summary":"今日百普赛斯(301080)涨6.54%,收盘报42.36元。2024年8月30日,开源证券研究员余汝意发布了对百普赛斯的研报《公司信息更新报告:常规业务稳健增长,高费用投入影响短期利润》,该研报对百普赛斯给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为67.81%。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为西南证券的杜向阳。百普赛斯(301080)个股概况:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500026586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","161027"],"gpt_icon":0},{"id":"2476796462","title":"百普赛斯(301080)5276.86万股限售股将于10月18日解禁,占总股本43.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476796462","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476796462?lang=zh_cn&edition=full","pubTime":"2024-10-18 08:04","pubTimestamp":1729209889,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,百普赛斯于10月18日将有5276.86万股限售股份解禁,为公司首发原股东限售股份,占公司总股本43.97%。本次解禁后,公司还有2941.38万股限售股份,占总股本24.51%。百普赛斯主营业务:提供重组蛋白等关键生物试剂产品及技术服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101800006626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","BK0216"],"gpt_icon":0},{"id":"2475742975","title":"百普赛斯(301080.SZ)5276.86万股限售股将于10月18日上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2475742975","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475742975?lang=zh_cn&edition=full","pubTime":"2024-10-15 19:23","pubTimestamp":1728991407,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百普赛斯(301080.SZ)公告,公司本次解除限售股东户数共计4户,解除限售股份的数量为5276.86万股,占公司总股本的43.9738%,上市流通日期为2024年10月18日(星期五)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1194367.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301080","BK0216"],"gpt_icon":0},{"id":"2475575960","title":"百普赛斯:约5276.86万股限售股10月18日解禁","url":"https://stock-news.laohu8.com/highlight/detail?id=2475575960","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475575960?lang=zh_cn&edition=full","pubTime":"2024-10-15 18:28","pubTimestamp":1728988080,"startTime":"0","endTime":"0","summary":"百普赛斯(SZ301080,收盘价:36.85元)10月15日晚间发布公告称,公司限售股份约5276.86万股将于2024年10月18日解禁并上市流通,占公司总股本比例约为43.97%。2023年1至12月份,百普赛斯的营业收入构成为:研究和试验发展占比98.0%,其他业务占比2.0%。截至发稿,百普赛斯市值为44亿元。(文章来源:每日经济新闻)\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-15/doc-incsruvp4266015.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-15/doc-incsruvp4266015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301080","BK0216"],"gpt_icon":0},{"id":"2474575870","title":"10月11日百普赛斯跌5.88%,圆信永丰聚优股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2474575870","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474575870?lang=zh_cn&edition=full","pubTime":"2024-10-11 16:40","pubTimestamp":1728636011,"startTime":"0","endTime":"0","summary":"证券之星消息,10月11日百普赛斯跌5.88%,收盘报37.65元,换手率4.06%,成交量2.72万手,成交额1.04亿元。根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为圆信永丰聚优股票A。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101100024292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","BK0216"],"gpt_icon":0},{"id":"2474721109","title":"10月9日百普赛斯跌12.77%,圆信永丰聚优股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2474721109","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474721109?lang=zh_cn&edition=full","pubTime":"2024-10-09 17:40","pubTimestamp":1728466851,"startTime":"0","endTime":"0","summary":"证券之星消息,10月9日百普赛斯跌12.77%,收盘报40.57元,换手率6.88%,成交量4.61万手,成交额1.98亿元。根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为圆信永丰聚优股票A。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100900031911.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","BK0216"],"gpt_icon":0},{"id":"2470777474","title":"9月27日百普赛斯涨7.22%,圆信永丰聚优股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2470777474","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470777474?lang=zh_cn&edition=full","pubTime":"2024-09-27 17:16","pubTimestamp":1727428592,"startTime":"0","endTime":"0","summary":"证券之星消息,9月27日百普赛斯涨7.22%,收盘报37.26元,换手率4.94%,成交量3.31万手,成交额1.21亿元。根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为圆信永丰聚优股票A。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092700026459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","BK0216"],"gpt_icon":0},{"id":"2470782774","title":"百普赛斯涨7.22%,开源证券四周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2470782774","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470782774?lang=zh_cn&edition=full","pubTime":"2024-09-27 17:16","pubTimestamp":1727428589,"startTime":"0","endTime":"0","summary":"今日百普赛斯(301080)涨7.22%,收盘报37.26元。2024年8月30日,开源证券研究员余汝意发布了对百普赛斯的研报《公司信息更新报告:常规业务稳健增长,高费用投入影响短期利润》,该研报对百普赛斯给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为67.81%。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为西南证券的杜向阳。百普赛斯(301080)个股概况:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092700026455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","301080"],"gpt_icon":0},{"id":"2468642678","title":"百普赛斯(301080.SZ)授出22.01万股预留限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2468642678","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468642678?lang=zh_cn&edition=full","pubTime":"2024-09-20 20:00","pubTimestamp":1726833615,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百普赛斯(301080.SZ)发布公告,公司于2024年9月20日召开了第二届董事会第九次会议和第二届监事会第九次会议,审议通过了《关于向2023年限制性股票激励计划激励对象授予预留限制性股票的议案》,确定限制性股票的预留授予日为2024年9月20日。预留授予数量22.01万股,预留授予价格32.68元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1185424.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","301080"],"gpt_icon":0},{"id":"2465604557","title":"百普赛斯新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2465604557","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465604557?lang=zh_cn&edition=full","pubTime":"2024-09-07 13:30","pubTimestamp":1725687052,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日北京百普赛斯生物科技股份有限公司新提交1件商标注册申请。商标申请详情如下:今年以来北京百普赛斯生物科技股份有限公司新申请注册商标39件,截止目前公司共持有注册商标222件,另有69件商标尚在注册申请中。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090700006999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","BK0216"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-10-18","address":"北京市大兴区北京经济技术开发区宏达北路8号4幢4层","stockEarnings":[{"period":"1week","weight":0.0413},{"period":"1month","weight":0.2462},{"period":"3month","weight":0.213},{"period":"6month","weight":0.1438},{"period":"1year","weight":-0.2919},{"period":"ytd","weight":-0.2047}],"companyName":"北京百普赛斯生物科技股份有限公司","boardCode":"AI0073","perCapita":"6411股","boardName":"研究和试验发展","registeredCapital":"12000万元","compareEarnings":[{"period":"1week","weight":-0.0352},{"period":"1month","weight":0.0399},{"period":"3month","weight":0.1567},{"period":"6month","weight":0.056},{"period":"1year","weight":0.0917},{"period":"ytd","weight":0.1196}],"survey":" 北京百普赛斯生物科技股份有限公司是一家专业提供重组蛋白等关键生物试剂产品及技术服务的高新技术企业。公司主要产品为重组蛋白、试剂盒、抗体、生物分析检测服务。","serverTime":1731698353275,"listedPrice":112.5,"stockholders":"14128人(较上一季度减少9.29%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百普赛斯(301080)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百普赛斯(301080)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百普赛斯,301080,百普赛斯股票,百普赛斯股票老虎,百普赛斯股票老虎国际,百普赛斯行情,百普赛斯股票行情,百普赛斯股价,百普赛斯股市,百普赛斯股票价格,百普赛斯股票交易,百普赛斯股票购买,百普赛斯股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百普赛斯(301080)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百普赛斯(301080)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}